Medical News

RSS

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.

24 Feb 2010

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

As part of John Muir Health’s Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy – removal of the thymus gland – was successfully performed recently at the John Muir Medical Center – Concord Campus. This procedure, designed to minimize trauma to patients, uses the latest generation da Vinci® Si Surgical System to help surgeons see vital anatomical structures more clearly and to perform a more precise operation.

24 Feb 2010

House to vote on ending insurer antitrust exemption today, White House backs measure

The Obama administration is supporting a House bill that would end the federal antitrust exemption for health insurers.

24 Feb 2010

Democrats revisit reconciliation as means to pass overhaul

Reconciliation, a parliamentary tactic that could allow Congress to pass health reform with a simple Senate majority, was dismissed weeks ago by centrist Democrats, but some of those lawmakers are now warming to the approach, clearing a possible avenue for passage of the overhaul, Politico reports. "Obviously, if the minority is just frustrating the process, that argues for taking steps to get the public's business done," said Sen. Evan Bayh, D-Ind., one of the senators to reverse course on reconciliation (Budoff Brown, 2/23).

24 Feb 2010

Researchers to test Radio-embolisation technique in patients with bowel cancer

Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.

24 Feb 2010

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

24 Feb 2010

Anthem Blue Cross will go forward with rate hikes, execs tell Calif. lawmakers

Anthem Blue Cross executives told California lawmakers Tuesday that they plan to go ahead with a rate hike of up to 39 percent for individual health insurance policies.

24 Feb 2010

Abortion, public option questions remain

The Wall Street Journal: "Abortion was one of the final matters to be resolved in December when the Senate created its version of the health-care bill, with a carefully crafted compromise that left neither side in the debate happy.

24 Feb 2010

Unique technology identifies drug candidates, speeds up drug development

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate.

From NanoTemper Technologies 24 Feb 2010

American People's Online Health Summit to be hosted in response to bipartisan health summit

In response to President Barack Obama's bipartisan health summit on February 25, Newt Gingrich's Center for Health Transformation will host the "American People's Online Health Summit," a LIVE blog to engage the American people in health reform negotiations and give them a voice in Washington.

24 Feb 2010

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.

24 Feb 2010

Eaton to supply $8M in electrical products and services to support consolidation of two medical centers

Diversified industrial manufacturer Eaton Corporation (NYSE:ETN) today announced that it will supply $8 million in electrical products and services to support the consolidation of two medical centers into the new San Antonio Military Medical Center on the Fort Sam Houston Army base in Texas.

24 Feb 2010

Researchers team up to monitor and assess potential infectious disease threats to Vancouver

As the world watches the Vancouver Olympics, researchers at St. Michael's Hospital in Toronto and Children's Hospital Boston have teamed up to monitor and assess potential infectious disease threats to Vancouver during the Winter Games by integrating two independently developed intelligence systems that focus on global infectious diseases; bio.DIASPORA and HealthMap.

24 Feb 2010

Centrist Dems have mixed responses to new Obama health plan

"The sweeping health-care package unveiled this week by the White House appears to face big hurdles in the House, with abortion and unease among moderates potential stumbling blocks to winning passage of the legislation," The Wall Street Journal reports. President Obama's proposal Monday has "drawn mixed reviews from moderate Democrats," who face electoral pressures and in some cases dispute specific policy ideas. Sen. Ben Nelson, D-Neb., for instance, "criticized a new White House provision that would give the federal government powers to hold down insurance premiums, saying that should be up to the states" (Adamy and Hitt, 2/24).

24 Feb 2010

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.

24 Feb 2010

Reid wants COBRA subsidy extension, eyes Medicaid funds for states

Senate Majority Leader Harry Reid is trying to extend unemployment benefits, health insurance subsidies for those recently laid-off and help for state Medicaid budgets that would in total cost $100 billion, The Associated Press reports. The measure is separate from the jobs bill. "Facing a Feb. 28 deadline, Reid hopes to pass two measures, one as soon as possible. The first includes a 30-day extension of several of soon-to-expire provisions such as jobless aid, parts of the Patriot Act and prevention of cuts in Medicare payments to doctors."

24 Feb 2010

A bird's-eye view of health overhaul lobbying

The Center for Public Integrity's new "analysis of Senate lobbying disclosure forms shows that more than 1,750 companies and organizations hired about 4,525 lobbyists — eight for each member of Congress — to influence health reform bills in 2009."

24 Feb 2010

Holy Name Hospital implements Fujitsu PalmSecure authentication technology for patient registration and identification

Fujitsu Frontech North America Inc., a leading supplier of innovative computer products including peripherals and biometric security solutions, today announced that Holy Name Hospital in Teaneck, N.J. is the first hospital in New Jersey to implement the Fujitsu PalmSecure™ palm vein authentication technology for patient registration and identification. The Fujitsu PalmSecure biometric solution integrates into Holy Name's new Palm First registration system to bolster security of medical records and enhance the overall patient experience.

24 Feb 2010

InfraReDx to exhibit novel LipiScan Coronary Imaging System at LUMEN 2010

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased intracoronary tissues, today announced that the Company will be exhibiting at LUMEN 2010, the world's premier ST-elevation myocardial infarction (STEMI) meeting, to be held February 25-27, 2010 at the Loews Miami Beach Hotel in Miami Beach, Florida. The 9th Annual LUMEN meeting is an educational symposium providing updates from world-renowned experts in key areas of interventional cardiology and vascular intervention.

24 Feb 2010

Meditation improves cognition in people with memory loss

The Alzheimer's Research and Prevention Foundation today announced data demonstrating that a specific meditation performed daily for eight weeks increased brain activity in areas central to memory and actually improved cognition in patients suffering from memory problems. The results of the study, conducted at the University of Pennsylvania, were published in an early online version of an article scheduled to appear in the Journal of Alzheimer's Disease (Volume 20:2, April 2010).

24 Feb 2010

Medical News

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

House to vote on ending insurer antitrust exemption today, White House backs measure

Democrats revisit reconciliation as means to pass overhaul

Researchers to test Radio-embolisation technique in patients with bowel cancer

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Anthem Blue Cross will go forward with rate hikes, execs tell Calif. lawmakers

Abortion, public option questions remain

Unique technology identifies drug candidates, speeds up drug development

American People's Online Health Summit to be hosted in response to bipartisan health summit

Novelos Therapeutics' NOV-002 Phase 3 NSCLC trial fails to meet primary survival endpoint

Eaton to supply $8M in electrical products and services to support consolidation of two medical centers

Researchers team up to monitor and assess potential infectious disease threats to Vancouver

Centrist Dems have mixed responses to new Obama health plan

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

Reid wants COBRA subsidy extension, eyes Medicaid funds for states

A bird's-eye view of health overhaul lobbying

Holy Name Hospital implements Fujitsu PalmSecure authentication technology for patient registration and identification

InfraReDx to exhibit novel LipiScan Coronary Imaging System at LUMEN 2010

Meditation improves cognition in people with memory loss

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News